N-(piperidin-1-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1^λ6-1,2,6-thiadiazine-5-carboxamide | 936756-61-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(piperidin-1-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1^λ6-1,2,6-thiadiazine-5-carboxamide
• 英文别名: 6-benzyl-5-methyl-1,1-dioxo-N-piperidin-1-yl-1,2,6-thiadiazine-3-carboxamide
• CAS: 936756-61-5
• 化学式: C₁₇H₂₂N₄O₃S
• 分子量: 362.453
• InChiKey: INRPBNZUYALETR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  90.5
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1^λ6-1,2,6-thiadiazine-5-carboxylic acid ethyl ester 、 1-氨基哌啶 在 三甲基铝 作用下， 以 正己烷 、 二氯甲烷 为溶剂， 反应 24.0h， 以29%的产率得到N-(piperidin-1-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1^λ6-1,2,6-thiadiazine-5-carboxamide
  参考文献：
  名称：

  Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity

  摘要：

  A series of new 2-substituted 1,1-dioxo-1,2,6-thiadiazine-5-carboxylate derivatives have been prepared from monosubstituted sulfamides in order to obtain N-substituted1,1-dioxo-1,2,6-thiadiazine-5-carboxamides as novel cannabinoid derivatives, analogues of Rimonabant (SR141716A). Their potential functional activity on cannabinoid receptors has been evaluated in vitro and in vivo in mice, showing that two compounds (37 and 39) behave as cannabinoid agonists in vitro. Their potency is lower than that of the reference compound, WIN 55,212-2, but their efficacy is similar to that of this cannabinoid agonist, although no in vivo activity is observed. Another derivative (38) behaves as a cannabinoid antagonist both in vitro and in vivo, being its efficacy and potency similar to that of the well-known antagonist SR141716A. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.07.056

文献信息

• Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity
  作者：Carolina Cano、Pilar Goya、Juan Antonio Paez、Rocío Girón、Eva Sánchez、María Isabel Martín

  DOI：10.1016/j.bmc.2007.07.056

  日期：2007.12

  A series of new 2-substituted 1,1-dioxo-1,2,6-thiadiazine-5-carboxylate derivatives have been prepared from monosubstituted sulfamides in order to obtain N-substituted1,1-dioxo-1,2,6-thiadiazine-5-carboxamides as novel cannabinoid derivatives, analogues of Rimonabant (SR141716A). Their potential functional activity on cannabinoid receptors has been evaluated in vitro and in vivo in mice, showing that two compounds (37 and 39) behave as cannabinoid agonists in vitro. Their potency is lower than that of the reference compound, WIN 55,212-2, but their efficacy is similar to that of this cannabinoid agonist, although no in vivo activity is observed. Another derivative (38) behaves as a cannabinoid antagonist both in vitro and in vivo, being its efficacy and potency similar to that of the well-known antagonist SR141716A. (c) 2007 Elsevier Ltd. All rights reserved.